MPLS, MINN – 2.1.2022 – Medspira has been awarded a group purchasing agreement with Premier, Inc, effective February 1st, 2022. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the Medspira mcompass® device.
“We’re excited by this opportunity to work with Premier to get Medspira’s mcompass devices to more physicians and help them better serve their patients and grow their practices,” says Evan Johnston, CEO of Medspira. “This truly is a better, simpler way to provide lower GI diagnostic and therapeutic care for so many patients.”
Leading medical professionals count on the mcompass anorectal manometry diagnostic and biofeedback therapy devices to help them do more for more patients. The mcompass device is the first and leading choice for portable anorectal manometry. Medical professionals can use the biofeedback system in pelvic floor therapy as they treat a range of conditions, including fecal incontinence, chronic constipation, and urinary incontinence related to childbirth and other traumas.
Premier is a leading healthcare improvement company, uniting an alliance of more than 4,400 U.S. hospitals and 225,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.
Medspira makes clinically inspired medical devices available to more health care professionals and their patients. The products of top researchers and inventors, developed and perfected in the exam and operating rooms of the nation's leading hospitals, these devices have the potential to help provide better results to more patients.
Learn more about the benefits of mcompass.